ReviewCancer management and research2022

The Path to Personalized Treatment in KRAS-Mutant Non-Small Cell Lung Cancer: A Review of Targeted Therapies and Immunotherapy.

Chun-Lu Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.